SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-017401
Filing Date
2006-03-16
Accepted
2006-03-16 16:56:00
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-2616_110k.htm 10-K 1577448
2 MATERIAL CONTRACTS a06-2616_1ex10d40.htm EX-10.40 434231
3 MATERIAL CONTRACTS a06-2616_1ex10d41.htm EX-10.41 49362
4 CONSENTS OF EXPERTS AND COUNSEL a06-2616_1ex23d1.htm EX-23.1 3588
5 302 CERTIFICATION a06-2616_1ex31d1.htm EX-31.1 9660
6 302 CERTIFICATION a06-2616_1ex31d2.htm EX-31.2 9751
7 906 CERTIFICATION a06-2616_1ex32.htm EX-32 5706
  Complete submission text file 0001104659-06-017401.txt   2091234
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 06692673
SIC: 2835 In Vitro & In Vivo Diagnostic Substances